CAS No. |
17598-65-1 |
|---|---|
中文名称 |
4-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-二羟基-3-[[(2R,4S,5S,6R)-4-羟基-5-[[(2S,4S,5S,6R)-4-羟基-5-[[(2S,4S,5S,6R)-4-羟基-6-甲基-5-[[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基]氧基]四氢-2H-吡喃-2-基]氧基]-6-甲基四氢-2H-吡喃-2-基]氧基]-6-甲基四氢-2H-吡喃-2-基]氧基]-10,13-二甲基十六氢-1H-环戊并[a]菲-17-基]呋喃-2(5H)-酮 |
英文名称 |
4-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-(((2R,4S,5S,6R)-4-hydroxy-5-(((2S,4S,5S,6R)-4-hydroxy-5-(((2S,4S,5S,6R)-4-hydroxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one |
别名 |
deslanoside | CAS-17598-65-1 | Deslanatoside C | NCGC00159441-03 | Deslanosid | SCHEMBL125311 | (3beta,5beta,12beta)-3-{[beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-bet |
标准英文名 |
4-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-(((2R,4S,5S,6R)-4-hydroxy-5-(((2S,4S,5S,6R)-4-hydroxy-5-(((2S,4S,5S,6R)-4-hydroxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one |
MDL No. |
- |
分子式 |
C47H74O19 |
分子量 |
943.09 |
精确分子量 |
942.48 |
SMILES |
C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@@H](O)[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1 |
标准SMILES |
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@@]21O)C1COC(=O)C=1)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1 |
用途 |
Treatment of acute and chronic heart failure, atrial fibrillation, and paroxysmal supraventricular tachycardia; used in research on congestive heart failure and supraventricular arrhythmias caused by re-entry mechanisms; control of ventricular rate in chronic atrial fibrillation; increases forearm blood flow and cardiac index while decreasing heart rate and skeletal muscle sympathetic nerve activity. |
InChIKey |
OBATZBGFDSVCJD-LALPQLPRSA-N |
|
|
评论 |
|---|